Poland· PL-100027757
Gynalgin
A imidazol-kombinationen product containing metronidazolum + chlorquinaldolum, registered in Poland by Bausch Health Ireland Ltd.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Imidazol-kombinationen is registered in 2 of 19 countries.
Countries holding a registration under ATC G01AF20 (imidazol-kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Imidazol-kombinationen · ATC G01AF20
2 / 19 countries
- Czechiaprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Metronidazolum + Chlorquinaldolum
- Manufacturer
- Bausch Health Ireland Ltd.
- Country
- Poland (PL)
- ATC code
- G01AF20
- ATC class
- Imidazol-Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990167210
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under G01AF20
Imidazol-kombinationen, as other registers publish it.
- PolandGynalginPharmapoint SA
- PolandGynalginForfarm Sp. z o.o.
- PolandGynalginPharmaVitae Sp. z o.o. sp. k.
- PolandGynalginAllpharm Sp. z o.o. sp.k.
- PolandGynalginInPharm Sp. z o.o.
- PolandGynalginDelfarma Sp. z o.o.
- PolandGynalginMedezin Sp. z o.o.
- CzechiaKLION-DGedeon Richter Plc., Budapešť
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Bulgaria · Гиналгин
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dbd14857-4f45-477d-92bd-0dd029c7762a GET /v1/drugs/dbd14857-4f45-477d-92bd-0dd029c7762a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki dopochwowe",
"source": "urpl",
"strength": "250 mg +100 mg",
"packaging": "05909990167210 ¦ Rp ¦ 4451\n10 tabl.",
"substance": "Metronidazolum ok. 7,2 mg + Chlorquinaldolum 100 mg",
"common_name": "Metronidazolum + Chlorquinaldolum",
"pl_product_id": "100027757",
"pozwolenie_nr": "01672",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about imidazol-kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.